NDC 0904-6875

Atazanavir Sulfate

Atazanavir

Atazanavir Sulfate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Atazanavir Sulfate.

Product ID0904-6875_37b8fbea-b1d0-451e-b2bc-ef8957e12fb6
NDC0904-6875
Product TypeHuman Prescription Drug
Proprietary NameAtazanavir Sulfate
Generic NameAtazanavir
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2018-06-25
Marketing CategoryANDA / ANDA
Application NumberANDA204806
Labeler NameMajor Pharmaceuticals
Substance NameATAZANAVIR SULFATE
Active Ingredient Strength300 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0904-6875-04

30 BLISTER PACK in 1 CARTON (0904-6875-04) > 1 CAPSULE in 1 BLISTER PACK
Marketing Start Date2018-06-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0904-6875-04 [00904687504]

Atazanavir Sulfate CAPSULE
Marketing CategoryANDA
Application NumberANDA204806
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-06-25

Drug Details

Active Ingredients

IngredientStrength
ATAZANAVIR SULFATE300 mg/1

Pharmacological Class

  • HIV Protease Inhibitors [MoA]
  • Protease Inhibitor [EPC]
  • UGT1A1 Inhibitors [MoA]
  • UDP Glucuronosyltransferases Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • HIV Protease Inhibitors [MoA]
  • Protease Inhibitor [EPC]
  • UGT1A1 Inhibitors [MoA]
  • UDP Glucuronosyltransferases Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]

NDC Crossover Matching brand name "Atazanavir Sulfate" or generic name "Atazanavir"

NDCBrand NameGeneric Name
0093-5526Atazanavir SulfateAtazanavir Sulfate
0093-5527Atazanavir SulfateAtazanavir Sulfate
0093-5528Atazanavir SulfateAtazanavir Sulfate
0904-6875Atazanavir SulfateAtazanavir
16714-860Atazanavir SulfateAtazanavir
16714-861Atazanavir SulfateAtazanavir
16714-862Atazanavir SulfateAtazanavir
70518-1365Atazanavir SulfateAtazanavir Sulfate
70518-0946Atazanavir SulfateAtazanavir Sulfate
51407-172Atazanavir SulfateAtazanavir Sulfate
51407-171Atazanavir SulfateAtazanavir Sulfate
51407-173Atazanavir SulfateAtazanavir Sulfate
60687-399Atazanavir SulfateAtazanavir Sulfate
65862-712Atazanavir SulfateAtazanavir Sulfate
65862-713Atazanavir SulfateAtazanavir Sulfate
65862-710Atazanavir SulfateAtazanavir Sulfate
65862-711Atazanavir SulfateAtazanavir Sulfate
31722-653AtazanavirAtazanavir
31722-654AtazanavirAtazanavir
31722-655AtazanavirAtazanavir
42385-920AtazanavirAtazanavir
0003-3622REYATAZATAZANAVIR
0003-3624REYATAZATAZANAVIR
0003-3631REYATAZATAZANAVIR
0003-3638REYATAZATAZANAVIR
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.